Drone Law Seminar November 2nd, 2016Drones/UAV Events Operating a drone, even a small one for recreational purposes, has legal implications for the operator and owner. Commercial operators have greater restrictions. These range from operational regulations and restrictions under Federal and State law, to privacy, trespass and nuisance issues, to tort liability for damage to property or individuals. Staying out in front of this technological wave is a business imperative: Business Insider adjusted its estimates of the drone market in 2020-21 from $1 billion in a 2014 report to $12 billion in a recent report. The Seminar Read More
Mobile Labs Receives Patent for Mobile Device Cloud November 1st, 2016Mobility Law & Compliance Press Release via: PC Business Products November 1, 2016 Mobile Labs has been awarded a third patent relating to the deviceConnect mobile device cloud. The new patent joins two others the U.S. Patent and Trademark Office has awarded Mobile Labs in the past year. These patents recognize our development team’s leading innovations in accurate and high-performance mobile app and device test automation tools, platforms, and management, said Don Addington, President and CEO of Mobile Labs. We are pleased the U.S. Patent and Trademark Office has recognized their achievements. The Mobile Labs patent applications were managed by the Atlanta law firm of Morris, Read More
MACRA: How IT Can Support Physician Reimbursement October 19th, 2016Health IT Events The Medicare Access and CHIP Re-authorization Act (“MACRA”) aims to change up the reimbursement landscape. MACRA intends to transform the fee-for-service system to a value-based and quality model. This Event will Review the details of the two payment models proposed under MACRA; specifically, the Medicare Incentive Based Payment System (“MIPS”) and the Alternative Payment Models (“APMs”) and how information technology or practice activities can support Physician reimbursement from Medicare. New regulations can be confusing and frustrating. Join TAG Health and a panel of industry experts as we breakdown this new regulation. Panelists: •Sherry Read More
Health Futures Forum: Congress, Commerce and Care October 10th, 2016Events & Associations, Health IT Events In this Health Futures Forum session, we engage leading voices from three critical dimensions of influence on the future of Health – governmental, market innovation and the training and delivery of health services. The nexus of these three worlds offer significant insight on the future enrichment of health of individuals and our society. The 21st century offers exceptional opportunities in science, process innovation and awareness of health possibilities. It is incumbent on all relevant parties to address the challenges faced by the traditional venues of health assistance. Research, methods and processes all transform Read More
Commercial Offer For Sale Does Not Include Third Party Manufacturing Services July 18th, 2016Life Sciences/Pharma By Mary An Merchant, PhD & Richard T. Timmer The biopharmaceutical world breathed a collective sigh of relief when the Court of Appeals for the Federal Circuit (“CAFC”) issued its ruling regarding the “on sale bar” as it relates to patent eligibility. In the ruling on Monday, July 11, 2016, the CAFC in The Medicines Company v. Hospira, Inc.(CAFC Case No. 2014-1469, 2014-1504) affirmed the district court ruling and held that to be “on sale” under 35 U.S.C. § 102(b), “a product must be the subject of a commercial sale or offer Read More
Notice By Biosimilar Maker To Biologic Originator Is Always Required July 6th, 2016Life Sciences/Pharma By Mary An Merchant, PhD & Richard Timmer The Court of Appeals for the Federal Circuit (“CAFC”) issued an important ruling today in the ongoing evolution of biosimilar product regulation. In the ruling today, the CAFC in Amgen Inc., Amgen Manufacturing Limited v. Apotex Inc., Apotex Corp. (CAFC Case No. 2016-1308) affirmed the district court ruling and held that the commercial-marketing provision in 42 U.S.C. § 262(l)(8)(A) is mandatory and enforceable by injunction, even where the biosimilar applicant has triggered the “patent dance” provisions of the BCPOA by providing Read More
Brexit and EU Privacy June 28th, 2016Data Security-Privacy By Paul Arne The decision of the United Kingdom to leave the European Union certainly has raised a large number of questions about what things will look like both when and before the dust settles. One issue that will need to be resolved relates to personal privacy. After exit from the EU, will the UK’s laws related to privacy allow personal data to be sent from the EU to the UK? What will the UK require for data transfers to the U.S.? Currently, protecting the privacy of personal information is mostly governed by the EU’s “Data Directive” (Directive 95/46/EC). Read More
What Brexit Means For Patents, Trademarks And Enforcement June 27th, 2016Patents/IP, Recent Legal News By Mary An Merchant, PhD Brexit, the United Kingdom’s vote to leave the European Union, raises many questions and some are related to intellectual property issues. There are a few anticipated changes to IP rights due to Brexit. Here is a summary of some key issues, and what could happen next. Trademarks and Designs Procedures for treatment of EU trademarks will need to be an element of the negotiations for the UK in leaving the EU. Trademarks can filed individually in each EU Read More
FAA Releases Long-Awaited Small UAS Rule June 22nd, 2016Drones/UAV In today’s news, AUVSI, Bloomberg and USA Today covered the release of the highly anticipated FAA small UAS rule. Under the small UAS rule, operators will be able to fly a UAS weighing less than 55 pounds at 400 feet or below without first obtaining FAA permission. The reports quote AUVSI President and CEO Brian Wynne, who calls the release of the rule “a significant milestone.” AUVSI has been pushing FAA to release a rule for years. Wynne says the rule will “accelerate the process of understanding what the risks are that will allow us Read More
Women in Business – North America Summit June 15th, 2016Entrepreneurial Info, Events & Associations Events Morris, Manning & Martin, LLP is pleased to sponsor the Women in Business North America Summit, hosted by Global Affairs Canada and the Canadian Trade Commissioner. Women-owned businesses in innovative technologies across multiple sectors from Canada, the United States and Mexico will participate in this unique event organized in conjunction with the Consulate General of Canada in Atlanta. Matchmaking opportunities for technology partnerships and global value chain expansion opportunities (pipeline/funding/export) will be made available for delegates with companies from the Southeast USA and Mexico. The event offers delegates exclusive access to connect to potential business opportunities with Fortune 500 Read More